Abiraterone acetate zecyte

Get a Price/Quote

MOQ : 2 Boxes

Abiraterone acetate zecyte Specification

Dosage Form
Tablets

Salt Composition
Abiraterone Acetate

Indication
Prostate Cancer

Enzyme Types
CYP17A1 Inhibitor

Feature
Prescription medicine, oral administration

Ingredients
Abiraterone Acetate 250mg

Application
Used in treatment of metastatic castration-resistant prostate cancer

Physical Color/Texture
White to off-white, film-coated tablet

Fermentation Smell
Odorless

Enzymatic Activity
Inhibits CYP17 enzyme activity

Storage Instructions
Store below 30C, keep in a dry place, protect from light and moisture

Shelf Life
24 months

ATC Code
L02BX03

Route of Administration
Oral

Patient Population
Adult males

Strength
250 mg per tablet

Prescription/Non Prescription
Prescription

Marketed By
Cipla

Packaging Size
120 tablets (4 strips of 30 tablets each)

Brand Name
Zecyte

About Abiraterone acetate zecyte

Zecyte (Abiraterone acetate) 250 mg is a meritorious treatment option, highly recommended for adult males combating metastatic castration-resistant prostate cancer. Manufactured by Cipla and presented in competitive pricing, this sought-after and phenomenal pharmaceutical is supplied as 120 oral tablets (4 strips of 30) that are white to off-white, film-coated, and odorless. As a CYP17A1 inhibitor, Zecyte effectively suppresses androgen production, crucial for prostate cancer control. With a shelf life of 24 months, it is prescription-only-secure your last chance today for access to a trusted solution distributed across India.

Broad Suitability and Practical Applications

Zecyte (Abiraterone acetate) is suitable for use in adult males diagnosed with metastatic castration-resistant prostate cancer. Its primary application area is in advanced oncology care settings where oral tablets can be easily administered. The application surface refers to systemic, oral administration, enabling effective CYP17 enzyme inhibition to manage cancer progression. Zecyte is prescribed as part of an informed, meritorious cancer therapy regimen for those in need of reliable, evidence-based solutions.

Reliable Supply, Market Reach, and Quotations

Zecyte is readily available with high supply ability throughout India, distributed by Cipla and supported by a network of trusted suppliers, traders, and distributors. The main domestic market ensures prompt delivery with express shipping options from the preferred FOB port. We offer transparent quotations and competitive list prices to meet market demands efficiently. Our robust distribution process supports timely access to this highly recommended medication, ensuring patients' needs are consistently met.

FAQ's of Abiraterone acetate zecyte:

Q: How should Zecyte (Abiraterone acetate) tablets be administered?

A: Zecyte tablets must be taken by mouth as prescribed by your healthcare provider, typically once daily on an empty stomach. Follow your doctor's instructions for optimal results.

Q: What are the main benefits of using Zecyte in prostate cancer treatment?

A: Zecyte effectively inhibits the CYP17 enzyme, reducing androgen production, which can help slow the growth and spread of metastatic castration-resistant prostate cancer.

Q: When is Zecyte prescribed for patients?

A: Zecyte is prescribed for adult males diagnosed with metastatic castration-resistant prostate cancer, especially when previous hormonal treatments are no longer effective.

Q: Where can I obtain Zecyte and is a prescription required?

A: Zecyte is available across India through authorized distributors, suppliers, and traders. It can only be dispensed with a valid prescription from a licensed medical professional.

Q: What is the process for obtaining a quotation or list price for Zecyte?

A: To receive a quotation or list price for Zecyte, contact your local authorized distributor or supplier, who can provide detailed pricing, availability, and options for express shipping.